Literature DB >> 21474414

Estimation of premature mortality from oral cancer in Japan, 1995 and 2005.

Haruhisa Ibayashi1, Truong-Minh Pham, Yoshihisa Fujino, Tatsuhiko Kubo, Kotaro Ozasa, Shinya Matsuda, Takesumi Yoshimura.   

Abstract

BACKGROUND: To better understand the picture of premature death from oral cancer, we estimated years of life lost (YLL) and average years of life lost (AYLL) of this cancer for the years 1995 and 2005 in Japan.
METHODS: We obtained the mortality data for 5-year age groups from the Vital Statistics of Japan for the years 1995 and 2005, an interval of 10 years. Age-standardized rates (ASRs) per 100,000 persons were calculated for each subset of oral cancer. We estimated YLL and AYLL according to life tables in Japan to reflect premature mortality.
RESULTS: For both men and women combined, 4099 and 5679 deaths due to oral cancer were recorded for the years 1995 and 2005. In men, cancer of tongue, oropharynx, and hypopharynx were the most frequently observed anatomic sites. We observed a total of 51,339.1 years of life lost in 1995 and 68,630.4 years in 2005, corresponding to an overall AYLL for all oral cancer deaths combined of 17.2 and 16.5 years earlier than life expectancy, respectively. The greatest AYLL was seen for deaths from nasopharyngeal cancer, with AYLL of 21.1 years in 1995 and 20.3 years in 2005. In women, cancer of the tongue and gum were the most affected anatomic sites. Total numbers of YLL were 18,884.8 years in 1995 and 24,765.7 in 2005, corresponding to an overall AYLL of 16.9 and 16.2 years earlier than life expectancy. The greatest AYLL was seen for deaths from nasopharyngeal cancer, with AYLL of 22.4 years and 20.4 years in 1995 and 2005, respectively.
CONCLUSION: The present study shows that cancer of pharynx, tongue, and gum were the most frequent oral cancers in both sexes in both 1995 and 2005, and responsible for a remarkable number of years of life expectancy lost. Deaths due to those cancer sites occurred about 16-21 years earlier than expected in men, and 14-22 years in women.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21474414     DOI: 10.1016/j.canep.2011.01.010

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  6 in total

1.  Mapping trends and hotspots regarding oral carcinoma and macrophages: a bibliometric analysis of global research.

Authors:  Tuan Zhao; Hao Hu; Xuan Chen; Ye Liu; Heng Wang; Xiaomei Li
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Deep learning model for tongue cancer diagnosis using endoscopic images.

Authors:  Jaesung Heo; June Hyuck Lim; Hye Ran Lee; Jeon Yeob Jang; Yoo Seob Shin; Dahee Kim; Jae Yol Lim; Young Min Park; Yoon Woo Koh; Soon-Hyun Ahn; Eun-Jae Chung; Doh Young Lee; Jungirl Seok; Chul-Ho Kim
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

3.  Potential years of life lost due to oropharyngeal cancer in Brazil: 1979 to 2013.

Authors:  Lillia Magali Estrada Perea; Alexandra Crispim Boing; Marco Aurélio Peres; Antonio Fernando Boing
Journal:  Rev Saude Publica       Date:  2019-09-02       Impact factor: 2.106

4.  Older age is a risk factor associated with poor prognosis of patients with squamous cell carcinoma of the oral cavity.

Authors:  Shuwei Chen; Zhu Lin; Jingtao Chen; Ankui Yang; Quan Zhang; Chuanbo Xie; Xing Zhang; Zhongyuan Yang; Wenkuan Chen; Ming Song
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-22       Impact factor: 2.503

5.  Life expectancy after HIV diagnosis based on data from the counseling center for behavioral diseases.

Authors:  Hassan Reza Mohammadi-Moein; Mohammad Reza Maracy; Katayoun Tayeri
Journal:  J Res Med Sci       Date:  2013-12       Impact factor: 1.852

6.  Burden of Oral Cancer on the 10 Most Populous Countries from 1990 to 2019: Estimates from the Global Burden of Disease Study 2019.

Authors:  Shu-Zhen Zhang; Long Xie; Zheng-Jun Shang
Journal:  Int J Environ Res Public Health       Date:  2022-01-13       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.